Camber Launches Colchicine Capsules
Click to listen to this article.
Piscataway, NJ, July 29, 2025 – As a leader in generic drug approvals and launches, Camber Pharmaceuticals is excited to announce the addition of Colchicine Capsules [coll-chi-seen] to its current portfolio.
Colchicine Capsules are indicated for prophylaxis of gout flares in adults. Colchicine works by stopping the natural processes that cause swelling and other symptoms of gout.
Colchicine Capsules are available in 0.6 mg, 30 and 100 count bottles.
To learn more about Colchicine Capsules, please visit: www.camberpharma.com/colchicine
Recent articles
- Camber Launches Abacavir and Lamivudine Tablets, USP
- Camber’s Parent Company, Hetero, Partners with the Gates Foundation to Supply Generic Lenacapavir for HIV Prevention
- Camber Adds 800 mg Darunavir Tablets to Product Family
- Camber Expands Portfolio with 10 New Generic Drug Launches in Q3 2025
- Camber Launches Indomethacin Suppositories
- Camber Launches Voriconazole for Injection





